Suppr超能文献

CD44v6.CAR T 细胞的特征描述和功能分析,这些细胞被赋予了一种新型低亲和力神经生长因子受体为基础的间隔物。

Characterization and Functional Analysis of CD44v6.CAR T Cells Endowed with a New Low-Affinity Nerve Growth Factor Receptor-Based Spacer.

机构信息

Research Department, AGC Biologics SpA (Formerly MolMed SpA), Milan, Italy.

Innovative Immunotherapies Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCSS San Raffaele Scientific Institute, Milan, Italy; and.

出版信息

Hum Gene Ther. 2021 Jul;32(13-14):744-760. doi: 10.1089/hum.2020.216. Epub 2021 May 5.

Abstract

Effectiveness of adoptively transferred chimeric antigen receptor (CAR) T cells strongly depends on the quality of CAR-mediated interaction of the effector cells with the target antigen on tumor cells. A major role in this interaction is played by the affinity of the single-chain variable fragment (scFv) for the antigen, and by the CAR design. In particular, the spacer domain may impact on the CAR T cell function by affecting the length and flexibility of the resulting CAR. This study addresses the need to improve the manufacturing process and the antitumor activity of CD44v6-specific CAR T cells by defining the optimal structure of a spacer region derived from the extracellular domain of the human low-affinity nerve growth factor receptor (LNGFR). We tailored the LNGFR spacer to modulate CAR length to efficiently recognize distal or proximal epitopes and to allow selection of transduced CAR T cells by the use of clinical-grade validated manufacturing systems. The different LNGFR spacers investigated in this study are responsible for the generation of CAR T cells with a different memory phenotype, which is mainly related to the level of CAR expression and the extent of the associated tonic signaling. In particular, the CD44v6-NWN2.CAR T cells are enriched in central memory cells and show improved functions in terms of killing capability, and antitumor activity against hematological and solid tumors. Clinical Trial Registration numbers: clinicaltrial.gov NCT04097301; ClinicalTrials.gov, NCT00423124.

摘要

嵌合抗原受体 (CAR) T 细胞的疗效在很大程度上取决于效应细胞与肿瘤细胞上靶抗原的 CAR 介导相互作用的质量。在这种相互作用中,单链可变片段 (scFv) 对抗原的亲和力和 CAR 设计起着重要作用。特别是间隔区域可能通过影响产生的 CAR 的长度和灵活性来影响 CAR T 细胞的功能。本研究通过定义源自人类低亲和力神经生长因子受体 (LNGFR) 细胞外结构域的间隔区的最佳结构,解决了改善 CD44v6 特异性 CAR T 细胞的制造工艺和抗肿瘤活性的需求。我们调整了 LNGFR 间隔区以调节 CAR 的长度,以有效识别远端或近端表位,并允许使用临床级验证的制造系统选择转导的 CAR T 细胞。本研究中研究的不同 LNGFR 间隔区负责产生具有不同记忆表型的 CAR T 细胞,这主要与 CAR 表达水平和相关紧张信号的程度有关。特别是,CD44v6-NWN2.CAR T 细胞富含中央记忆细胞,并在杀伤能力和针对血液系统和实体瘤的抗肿瘤活性方面表现出改善的功能。临床试验注册号:clinicaltrial.gov NCT04097301;ClinicalTrials.gov,NCT00423124。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7469/8312023/54b0de008419/hum.2020.216_figure1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验